SNA-11

N/A

Report date: 2023/08/01 18:02:00
NME

Base Information

Drug NameSNA-11
Drug Alias NameSynxyrinSNA-11
ClassificationOther
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyneurx International (Taiwan) Corp
China Registration ClassN/A

Develop Information

Active CompaniesSyneurx International (Taiwan) Corp
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A